Free Trial

This company has been marked as potentially delisted and may not be actively trading.

IVERIC bio (ISEE) News Today

IVERIC bio logo

ISEE Latest News

Astellas Pharma Inc (ALPMY)
Apellis adds safety warning to eye therapy
Astellas Completes Acquisition of Iveric Bio
IVERIC bio (Nasdaq:ISEE) Headline
Trading was temporarily halted for "ISEE" at 07:07 PM with a stated reason of "News pending."...
B.Riley Financial Sticks to Its Hold Rating for IVERIC bio (ISEE)
Iveric bio, Still A 5+% Opportunity
IVERIC Bio (NASDAQ: ISEE)
TD Cowen Downgrades IVERIC bio (ISEE)
Check Out What Whales Are Doing With ISEE
Get IVERIC bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter.

ISEE Media Mentions By Week

ISEE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ISEE
News Sentiment

0.45

0.58

Average
Medical
News Sentiment

ISEE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ISEE Articles
This Week

0

0

ISEE Articles
Average Week

Get IVERIC bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ISEE) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners